Skip to main content
. Author manuscript; available in PMC: 2018 Aug 14.
Published in final edited form as: ACS Biomater Sci Eng. 2017 Jun 9;3(8):1861–1868. doi: 10.1021/acsbiomaterials.7b00319

Scheme 1.

Scheme 1

Synthesis and fabrication of DNF and BT/DNF mats. Following the synthesis of PEGylated PAMAM dendrimer G3.0 (i.e., G3.0-mPEG), G3.0-mPEG is dissolved in HFIP with high molecular weight PEO in the absence or presence of the antiglaucoma drug BT and electrospun into DNF or BT/DNF mats.